Home  »  Companies   »  Roivant Sciences Ltd.: Is ROIV Stock Worth Buying?...

Roivant Sciences Ltd.: Is ROIV Stock Worth Buying?

The trading price of Roivant Sciences Ltd. (NASDAQ:ROIV) floating lower at last check on Wednesday, May 24, closing at $9.16, -2.40% lower than its previous close.

Traders who pay close attention to intraday price movement should know that it has been fluctuating between $9.33 and $9.85. In examining the 52-week price action we see that the stock hit a 52-week high of $10.00 and a 52-week low of $2.87. Over the past month, the stock has gained 4.86% in value.

25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


Roivant Sciences Ltd., whose market valuation is $6.95 billion at the time of this writing, is expected to release its quarterly earnings report Jun 26, 2023 – Jun 30, 2023. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.37 per share this quarter, however they have predicted annual earnings per share of -$1.64 for 2023 and -$1.35 for 2024. It means analysts are expecting annual earnings per share growth of -30.20% this year and 17.70% next year.

Analysts have forecast the company to bring in revenue of $20.45 million for the current quarter, with the likely lows of $13 million and highs of $36 million. The average estimate suggests sales will likely up by 121.70% this quarter compared to what was recorded in the comparable quarter last year. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2023 is $52.15 million. The company’s revenue is forecast to drop by -5.70% over what it did in 2023.

A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Roivant Sciences Ltd. No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest ROIV has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.

Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned ROIV a recommendation rating is 9. Out of them, 1 rate it a Hold, while 8 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Roivant Sciences Ltd. (ROIV) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.

A quick review shows that ROIV’s price is currently 2.97% off the SMA20 and 10.77% off the SMA50. The RSI metric on the 14-day chart is currently showing 55.67, and weekly volatility stands at 4.38%. When measured over the past 30 days, the indicator reaches 4.90%. Roivant Sciences Ltd. (NASDAQ:ROIV)’s beta value is currently sitting at 0, while the Average True Range indicator is currently displaying 0.44. With analysts defining $10.00-$19.00 as the low and high price targets, we arrive at a consensus price target of $14.00 for the trailing 12-month period. The current price is about -9.17% off the estimated low and -107.42% off the forecast high, based on this estimate. Investors will be thrilled if ROIV’s share price rises to $14.00, which is the median consensus price. At that level, ROIV’s share price would be -52.84% below current price.

To see how Roivant Sciences Ltd. stock has been performing today in comparison to its peers in the industry, here are the numbers: ROIV stock’s performance was -2.40% at last check in today’s session, and 151.10% in the past year. Also during today’s trading, the S&P 500 Index has plunged -0.71%, while the Dow Jones Industrial also saw a negative session, down -0.57% today.

An evaluation of the daily trading volume of Roivant Sciences Ltd. (NASDAQ:ROIV) indicates that the 3-month average is 3.05 million. However, this figure has increased over the past 10 days to an average of 2.46 million.

Currently, records show that 713.32 million of the company’s shares remain outstanding. The insiders hold 14.50% of outstanding shares, whereas institutions hold 51.20%. The stats also highlight that short interest as of Apr 27, 2023, stood at 14.02 million shares, resulting in a short ratio of 4.89 at that time. From this, we can conclude that short interest is 1.85% of the company’s total outstanding shares. It is noteworthy that short shares in April were up slightly from the previous month’s figure, which was 13.88 million. However, since the stock’s price has seen 14.71% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.

Leave a Comment

Your email address will not be published. Required fields are marked *